Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) will host a conference call to discuss financial results for the full-year ended December 31, 2023, on February 28, 2024, at 8:30 a.m. ET. Participants can access the call by phone or webcast through the Investors section of the company's website.

PRINCETON, N.J., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, February 28, 2024, at 8:30 a.m. ET to discuss financial results for the full-year ended December 31, 2023.

Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.

An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When will Amicus Therapeutics host a conference call to discuss financial results for the full-year ended December 31, 2023?

Amicus Therapeutics will host the conference call on February 28, 2024, at 8:30 a.m. ET.

How can participants access the conference call by phone?

Participants interested in accessing the call by phone will need to register using the online registration form and will receive a dial-in number and personal PIN to access the event.

Where can web participants access the live audio webcast and presentation materials?

Web participants can access the live audio webcast and related presentation materials via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com.

Is there an option to access the archived webcast and slides after the live event?

Yes, an archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.